Big Cat
04-26-2004, 08:00 AM
... brainpower we have in here. Below are some points I see as future targets of manipulation in mediating anabolism. Any and all input and thoughts are welcome. I will expand on these subjects further in due time, but as time escapes me, I will just post the subjects so we can get some input rolling :
Interleukin-15 : This particular cytokine has interested me for sometime, with the literature clearly demonstrating not only a distinct role for anabolism, but also a clear synergistic role with IGF's in this regard. IGF's exert most of their effects on sattelite cell proliferation, differentiation and fusion, while IL-15 works primarily on differentiated myofibers. This is however mostly a tease, since very little data is available on the exact manner in which IL-15 causes anabolism or how it could be manipulated.
IGF-II : IGF-II's anabolic potential is considerably larger than that of IGF-I. It works its magic via both the IGF-I receptor and the insulin receptor. In rodents, IGF-II expression is diminished postnatally, but not in humans, making it a legitimate point of manipulation. IGF-II is reduced strongly by the IGF-II/M6P receptor, making this one possible point of intervention. Insulin for instance increases IGF-IIR translocation, so methods of reducing insulin release would work. Only release however, since affecting insulin receptor or downstream targets thereof would reduce anabolic efficacy of IGF-II.
SOCS2 : IGF's and insulin work for the most part through three distinct downstream cascades. IGF-I principally mediates growth via the PI3K/PKB pathway and a little through the Ras/Raf/MEK/ERK pathway, and IL-15 the other way around. The third pathway is the JAK/STAT pathway and is often overlooked in regards to anabolism, its mostly directed at mediating immune signals. This pathway gets a negative feedback signal via SOCS proteins, 3 of them. Deletion of the SOCS1 and SOCS3 proteins, resulted in death, making it an unlikely point of manipulation. However SOCS2 deletion had only one side-effect : 30% increase in growth. That seems like a nice bonus, nay ?
Interleukin-15 : This particular cytokine has interested me for sometime, with the literature clearly demonstrating not only a distinct role for anabolism, but also a clear synergistic role with IGF's in this regard. IGF's exert most of their effects on sattelite cell proliferation, differentiation and fusion, while IL-15 works primarily on differentiated myofibers. This is however mostly a tease, since very little data is available on the exact manner in which IL-15 causes anabolism or how it could be manipulated.
IGF-II : IGF-II's anabolic potential is considerably larger than that of IGF-I. It works its magic via both the IGF-I receptor and the insulin receptor. In rodents, IGF-II expression is diminished postnatally, but not in humans, making it a legitimate point of manipulation. IGF-II is reduced strongly by the IGF-II/M6P receptor, making this one possible point of intervention. Insulin for instance increases IGF-IIR translocation, so methods of reducing insulin release would work. Only release however, since affecting insulin receptor or downstream targets thereof would reduce anabolic efficacy of IGF-II.
SOCS2 : IGF's and insulin work for the most part through three distinct downstream cascades. IGF-I principally mediates growth via the PI3K/PKB pathway and a little through the Ras/Raf/MEK/ERK pathway, and IL-15 the other way around. The third pathway is the JAK/STAT pathway and is often overlooked in regards to anabolism, its mostly directed at mediating immune signals. This pathway gets a negative feedback signal via SOCS proteins, 3 of them. Deletion of the SOCS1 and SOCS3 proteins, resulted in death, making it an unlikely point of manipulation. However SOCS2 deletion had only one side-effect : 30% increase in growth. That seems like a nice bonus, nay ?